HALO

HALOZYME THERAPEUTICS INC

Healthcare | Mid Cap

$0.98

EPS Forecast

$252.8

Revenue Forecast

The company already released most recent quarter's earnings. We will publish our AI's next quarter's forecast around 2024-12-31
DNLIDenali Therapeutics IncCRBUCaribou Biosciences IncIOVAIovance Biotherapeutics IncRVMDRevolution Medicines IncREPLReplimune Group Inc